Results 331 to 340 of about 273,161 (350)

A peripheral immune signature of responsiveness to PD-1 blockade in patients with classical Hodgkin lymphoma

Nature Medicine, 2020
Fathima Zumla Cader, Xihao Hu, Kirsty Wienand   +2 more
exaly  

The model of cytokine release syndrome in CAR T-cell treatment for B-cell non-Hodgkin lymphoma

Signal Transduction and Targeted Therapy, 2020
Guanghai Dai, Wei Wang, John E J Rasko
exaly  

The Non-Hodgkin lymphomas

Current Problems in Cancer, 1980
D L, Sweet, H M, Golomb
openaire   +2 more sources

Non-Hodgkin's Lymphoma

New England Journal of Medicine, 1980
openaire   +2 more sources

State of the art in the treatment of Hodgkin lymphoma

Nature Reviews Clinical Oncology, 2012
Peter Borchmann, Dennis A Eichenauer
exaly  

The biology of Hodgkin's lymphoma

Nature Reviews Cancer, 2008
Ralf Küppers
exaly  

Indolent Non-Hodgkin Lymphoma

2021
Christopher W. Fleming, Aryavarta M. S. Kumar, Matthew C. Ward   +2 more
openaire   +1 more source

Staging Non-Hodgkin Lymphoma

Ca-A Cancer Journal for Clinicians, 2005
exaly  

Anti-CD47 Antibody Synergizes with Rituximab to Promote Phagocytosis and Eradicate Non-Hodgkin Lymphoma

Cell, 2010
Ash A Alizadeh, June Helen Myklebust, Raquel Malumbres   +2 more
exaly  

The discovery and development of brentuximab vedotin for use in relapsed Hodgkin lymphoma and systemic anaplastic large cell lymphoma

Nature Biotechnology, 2012
Eric Louis Sievers
exaly